help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guse, A. H.
Right arrow Articles by Gercken, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guse, A. H.
Right arrow Articles by Gercken, G.

Endocrinology, Vol 130, 145-151, Copyright © 1992 by Endocrine Society


ARTICLES

Identification and characterization of insulin-like growth factor receptors on adult rat cardiac myocytes: linkage to inositol 1,4,5- trisphosphate formation

AH Guse, W Kiess, B Funk, U Kessler, I Berg and G Gercken
University of Hamburg, Department of Biochemistry, Germany.

Cultured cardiac myocytes from adult Sprague-Dawley rats express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose 6-phosphate (IGF-II/Man6P) receptors and respond to IGF-I with a dose-dependent accumulation of inositol 1,4,5- trisphosphate [Ins(1,4,5)P3] and inositol 1,4-bisphosphate [Ins(1,4)P2]. Specific binding of [125I]IGF-I to isolated membranes from cultured cardiac myocytes amounted to 1-1.2%. Binding of [125I]IGF- I was inhibited by unlabeled IGF-I at nanomolar concentrations and insulin at much higher concentrations. These data suggest that IGF-I binds to its own receptor on rat cardiac myocytes. Competitive binding studies using isolated membranes from cardiac myocytes and [125I]IGF-II showed 2-4% specific binding. Binding of [125I]IGF-II was inhibited by IGF-II and much less potently by IGF-I and insulin. Immunoglobulin G (IgG) 3637 (an IgG directed against the IGF-II/Man6P receptor) partially inhibited binding of [125I]IGF-II whereas nonimmune IgG did not. Affinity cross-linking studies with [125I]IGF-II and cardiac myocyte membranes and subsequent analysis of the ligand-receptor complex using SDS-PAGE and autoradiography showed a radiolabeled band of approximately 250 kilodalton (kDa). The formation of the [125I]IGF- II-receptor complex was inhibited by incubation with IGF-II and IgG 3637 but not by insulin or nonimmune IgG. Western blotting of protein extracts from cultured cardiac myocytes was performed using IgG 3637 and an immunoperoxidase technique for the visualization of the IGF- II/Man6P receptor protein. A specific band at 220 kDa under nonreducing conditions was detected on the blots, providing further evidence for the expression of the IGF-II/Man6P receptor by cardiac myocytes. The effect of IGFs on the accumulation of inositol phosphates was measured by HPLC analysis of perchloric acid extracts from myo-[3H]inositol- labeled cultured cardiac myocytes. IGF-I (50 ng/ml) stimulated the accumulation both of Ins(1,4,5)P3 and Ins(1,4)P2 after 30 sec by 43% and 63%. IGF-II (up to 500 ng/ml) had no significant effect on inositol phosphate accumulation under the same conditions. However, in the presence of millimolar concentrations of Man6P, IGF-II (500 ng/ml) also increased Ins(1,4,5)P3 accumulation by 59%. We conclude that cardiac myocytes from adult rats express IGF receptors and respond to IGFs with the accumulation of Ins(1,4,5)P3 and Ins(1,4)P2. This effect seems to be mediated by an IGF-I receptor-specific pathway.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
P. Maison, A.-I. Tropeano, I. Macquin-Mavier, A. Giustina, and P. Chanson
Impact of Somatostatin Analogs on the Heart in Acromegaly: A Metaanalysis
J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1743 - 1747.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. R. McMullen, T. Shioi, W.-Y. Huang, L. Zhang, O. Tarnavski, E. Bisping, M. Schinke, S. Kong, M. C. Sherwood, J. Brown, et al.
The Insulin-like Growth Factor 1 Receptor Induces Physiological Heart Growth via the Phosphoinositide 3-Kinase(p110{alpha}) Pathway
J. Biol. Chem., February 6, 2004; 279(6): 4782 - 4793.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Ren, J. Duan, K. K Hintz, and B. H Ren
High glucose induces cardiac insulin-like growth factor I resistance in ventricular myocytes: role of Akt and ERK activation
Cardiovasc Res, March 1, 2003; 57(3): 738 - 748.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Galderisi, G. Vitale, G. Lupoli, M. Barbieri, G. Varricchio, C. Carella, O. de Divitiis, and G. Paolisso
Inverse Association Between Free Insulin-Like Growth Factor-1 and Isovolumic Relaxation in Arterial Systemic Hypertension
Hypertension, October 1, 2001; 38(4): 840 - 845.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. McKinnon, C. Chakraborty, L. M. Gleeson, P. Chidiac, and P. K. Lala
Stimulation of Human Extravillous Trophoblast Migration by IGF-II Is Mediated by IGF Type 2 Receptor Involving Inhibitory G Protein(s) and Phosphorylation of MAPK
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3665 - 3674.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Colao, C. di Somma, A. Cuocolo, L. Spinelli, N. Tedesco, R. Pivonello, D. Bonaduce, M. Salvatore, and G. Lombardi
Improved Cardiovascular Risk Factors and Cardiac Performance after 12 Months of Growth Hormone (GH) Replacement in Young Adult Patients with GH Deficiency
J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 1874 - 1881.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
J. Ren
Attenuated cardiac contractile responsiveness to insulin-like growth factor I in ventricular myocytes from biobreeding spontaneous diabetic rats
Cardiovasc Res, April 1, 2000; 46(1): 162 - 171.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Ren, L. Jefferson, J. R. Sowers, and R. A. Brown
Influence of Age on Contractile Response to Insulin-Like Growth Factor 1 in Ventricular Myocytes From Spontaneously Hypertensive Rats
Hypertension, December 1, 1999; 34(6): 1215 - 1222.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
V. Bodart, J. F. Bouchard, N. McNicoll, E. Escher, P. Carriere, E. Ghigo, T. Sejlitz, M. G. Sirois, D. Lamontagne, and H. Ong
Identification and Characterization of a New Growth Hormone-Releasing Peptide Receptor in the Heart
Circ. Res., October 29, 1999; 85(9): 796 - 802.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. A. Yandell, A. J. Dunbar, J. F. Wheldrake, and Z. Upton
The Kangaroo Cation-independent Mannose 6-Phosphate Receptor Binds Insulin-like Growth Factor II with Low Affinity
J. Biol. Chem., September 17, 1999; 274(38): 27076 - 27082.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Kinugawa, H. Tsutsui, T. Ide, R. Nakamura, K.-i. Arimura, K. Egashira, and A. Takeshita
Positive inotropic effect of insulin-like growth factor-1 on normal and failing cardiac myocytes
Cardiovasc Res, July 1, 1999; 43(1): 157 - 164.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
V Gersl, J Cerman, P Suba, Y Mazurova, R Hrdina, and J Machackova
IGF-I in experimental daunorubicin-induced cardiomyopathy in rabbits
Human and Experimental Toxicology, March 1, 1999; 18(3): 154 - 161.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Baldelli, E. Ferretti, M.-L. Jaffrain-Rea, G. Iacobellis, G. Minniti, B. Caracciolo, C. Moroni, R. Cassone, A. Gulino, and G. Tamburrano
Cardiac Effects of Slow-Release Lanreotide, a Slow-Release Somatostatin Analog, in Acromegalic Patients
J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 527 - 532.
[Abstract] [Full Text]


Home page
J. Am. Soc. Nephrol.Home page
D. P. QING, H. DING, J. VADGAMA, Y. Y. WU, and J. D. KOPPLE
Elevated Myocardial Cytosolic Calcium Impairs Insulin-Like Growth Factor-1-Stimulated Protein Synthesis in Chronic Renal Failure
J. Am. Soc. Nephrol., January 1, 1999; 10(1): 84 - 92.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Ren, M. F. Walsh, M. Hamaty, J. R. Sowers, and R. A. Brown
Altered inotropic response to IGF-I in diabetic rat heart: influence of intracellular Ca2+ and NO
Am J Physiol Heart Circ Physiol, September 1, 1998; 275(3): H823 - H830.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Cittadini, Y. Ishiguro, H. Stromer, M. Spindler, A. C. Moses, R. Clark, P. S. Douglas, J. S. Ingwall, and J. P. Morgan
Insulin-like Growth Factor-1 but Not Growth Hormone Augments Mammalian Myocardial Contractility by Sensitizing the Myofilament to Ca2+ Through a Wortmannin-Sensitive Pathway : Studies in Rat and Ferret Isolated Muscles
Circ. Res., June 13, 1998; 83(1): 50 - 59.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. Sacca
Growth hormone: a newcomer in cardiovascular medicine
Cardiovasc Res, October 1, 1997; 36(1): 3 - 9.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Körner, B. Nürnberg, M. Uhde, and T. Braulke
Mannose 6-Phosphate/Insulin-like Growth Factor II Receptor Fails to Interact with G-proteins
J. Biol. Chem., January 6, 1995; 270(1): 287 - 295.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society